1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Biopharmaceuticals Market – by Product Type

1.3.2        Asia Pacific Biopharmaceuticals Market – by Application

1.3.3        Asia Pacific Biopharmaceuticals Market – by Country

2.           Asia Pacific Biopharmaceuticals Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Biopharmaceuticals Market – Market Landscape

4.1         Overview

4.2         Asia Pacific PEST Analysis

4.3         Expert’s Opinion

5.           Asia Pacific Biopharmaceuticals Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Application in Cancer Therapeutics

5.1.2        Potential to Treat Rare Diseases

5.2         Market Restraints

5.2.1        High Cost of Manufacturing Infrastructure

5.3         Market Opportunities

5.3.1        Accelerated Clinical Trials

5.4         Future Trends

5.4.1        Contract Manufacturing of Biopharmaceuticals

5.5         Impact Analysis

6.           Biopharmaceuticals Market – Asia Pacific Analysis

6.1         Asia Pacific Biopharmaceuticals Market Revenue Forecast and Analysis

7.           Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 – by Product Type

7.1         Overview

7.2         Asia Pacific Biopharmaceuticals Market Revenue Share, by Product Type 2021 & 2028 (%)

7.3         Monoclonal Antibodies

7.3.1        Overview

7.3.2        Monoclonal Antibodies: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Recombinant Vaccines

7.4.1        Overview

7.4.2        Recombinant Vaccines: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.1          Cancer Vaccine

7.4.2.1.1          Overview

7.4.2.1.2          Cancer Vaccine: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.2          Malaria Vaccine

7.4.2.2.1          Overview

7.4.2.2.2          Malaria Vaccine: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.3          Ebola Vaccine

7.4.2.3.1          Overview

7.4.2.3.2          Ebola Vaccine: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.4          Hepatitis-B Vaccine

7.4.2.4.1          Overview

7.4.2.4.2          Hepatitis-B Vaccine: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.5          Tetanus Vaccine

7.4.2.5.1          Overview

7.4.2.5.2          Tetanus Vaccine: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.6          Diphtheria Vaccine

7.4.2.6.1          Overview

7.4.2.6.2          Diphtheria Vaccine: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.7          Cholera Vaccine

7.4.2.7.1          Overview

7.4.2.7.2          Cholera Vaccine: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.8          Others

7.4.2.8.1          Overview

7.4.2.8.2          Others: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Conventional Vaccines

7.5.1        Overview

7.5.2        Conventional Vaccines: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.1          Polio Vaccine

7.5.2.1.1          Overview

7.5.2.1.2          Polio Vaccine: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.2          Pox Vaccine

7.5.2.2.1          Overview

7.5.2.2.2          Pox Vaccine: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.3          Other Conventional Vaccine

7.5.2.3.1          Overview

7.5.2.3.2          Other Conventional Vaccine: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Recombinant Growth Factors

7.6.1        Overview

7.6.2        Recombinant Growth Factors: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.1          Erythropoietin

7.6.2.1.1          Overview

7.6.2.1.2          Erythropoietin: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.6.2.2          Granulocyte Colony Stimulating Factor

7.6.2.2.1          Overview

7.6.2.2.2          Granulocyte Colony Stimulating Factor: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.7         Purified Proteins

7.7.1        Overview

7.7.2        Purified Proteins: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.7.2.1          Leukemia Inhibitory Factor (LIF)

7.7.2.1.1          Overview

7.7.2.1.2          Leukemia Inhibitory Factor (LIF): Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.7.2.2          P53 Protein

7.7.2.2.1          Overview

7.7.2.2.2          P53 Protein: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.7.2.3          P38 Protein

7.7.2.3.1          Overview

7.7.2.3.2          P38 Protein: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.7.2.4          Other Purified Proteins

7.7.2.4.1          Overview

7.7.2.4.2          Other Purified Proteins: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.8         Recombinant Proteins

7.8.1        Overview

7.8.2        Recombinant Proteins: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.8.2.1          Serum Albumin

7.8.2.1.1          Overview

7.8.2.1.2          Serum Albumin: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.8.2.2          Amyloid Protein

7.8.2.2.1          Overview

7.8.2.2.2          Amyloid Protein: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.8.2.3          Defensin

7.8.2.3.1          Overview

7.8.2.3.2          Defensin: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.8.2.4          Transferrin

7.8.2.4.1          Overview

7.8.2.4.2          Transferrin: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.9         Recombinant Hormones

7.9.1        Overview

7.9.2        Recombinant Hormones: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.9.2.1          Recombinant Human Growth Hormones

7.9.2.1.1          Overview

7.9.2.1.2          Recombinant Human Growth Hormones: Asia pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.9.2.2          Recombinant Insulin

7.9.2.2.1          Overview

7.9.2.2.2          Recombinant Insulin: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.9.2.3          Other Recombinant Hormones

7.9.2.3.1          Overview

7.9.2.3.2          Other Recombinant Hormones: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.10      Recombinant Enzymes

7.10.1     Overview

7.10.2     Recombinant Enzymes: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.10.2.1       Enterokinase

7.10.2.1.1       Overview

7.10.2.1.2       Enterokinase: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.10.2.2       Cyclase

7.10.2.2.1       Overview

7.10.2.2.2       Cyclase: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.10.2.3       Caspase

7.10.2.3.1       Overview

7.10.2.3.2       Caspase: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.10.2.4       Cathepsin

7.10.2.4.1       Overview

7.10.2.4.2       Cathepsin: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.11      Cell and Gene Therapies

7.11.1     Overview

7.11.2     Cell and Gene Therapies: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.11.2.1       Allogenic Products

7.11.2.1.1       Overview

7.11.2.1.2       Allogenic Products: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.11.2.2       Autologous Products

7.11.2.2.1       Overview

7.11.2.2.2       Autologous Products: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.11.2.3       Acellular Products

7.11.2.3.1       Overview

7.11.2.3.2       Acellular Products: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.12      Cytokines/Interferon/Interleukins

7.12.1     Overview

7.12.2     Cytokines/Interferon/Interleukins: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.13      Others (mRNA Based Therapeutics, etc.)

7.13.1     Overview

7.13.2     Others (mRNA Based Therapeutics, etc.): Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.           Asia Pacific Biopharmaceuticals Market Analysis and Forecasts to 2028 – by Application

8.1         Overview

8.2         Asia Pacific Biopharmaceuticals Market, by Application 2021 & 2028 (%)

8.3         Oncology

8.3.1        Overview

8.3.2        Oncology: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Inflammatory and Infectious Diseases

8.4.1        Overview

8.4.2        Inflammatory and Infectious Diseases: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Autoimmune Disorders

8.5.1        Overview

8.5.2        Autoimmune Disorders: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Metabolic Disorders

8.6.1        Overview

8.6.2        Metabolic Disorders: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.7         Hormonal Disorders and Growth Failure

8.7.1        Overview

8.7.2        Hormonal Disorders and Growth Failure: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.8         Cardiovascular Diseases

8.8.1        Overview

8.8.2        Cardiovascular Diseases: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.9         Neurological Diseases

8.9.1        Overview

8.9.2        Neurological Diseases: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.10      Other Therapeutic Applications

8.10.1     Overview

8.10.2     Other Therapeutic Applications: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.           Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 – Country Analysis

9.1         Overview

9.1.1        Asia Pacific: Biopharmaceuticals Market, by Country, 2021 & 2028 (%)

9.1.1.1          China: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.1          China: Biopharmaceuticals Market, by Product Type, 2019–2028 (US$ Million)

9.1.1.1.1.1        China: Biopharmaceuticals Market, by Recombinant Vaccines, 2019–2028 (US$ Million)

9.1.1.1.1.2        China: Biopharmaceuticals Market, by Conventional Vaccines, 2019–2028 (US$ Million)

9.1.1.1.1.3        China: Biopharmaceuticals Market, by Recombinant Growth Factors, 2019–2028 (US$ Million)

9.1.1.1.1.4        China: Biopharmaceuticals Market, by Purified Proteins, 2019–2028 (US$ Million)

9.1.1.1.1.5        China: Biopharmaceuticals Market, by Recombinant Proteins, 2019–2028 (US$ Million)

9.1.1.1.1.6        China: Biopharmaceuticals Market, by Recombinant Hormones, 2019–2028 (US$ Million)

9.1.1.1.1.7        China: Biopharmaceuticals Market, by Recombinant Enzymes, 2019–2028 (US$ Million)

9.1.1.1.1.8        China: Biopharmaceuticals Market, by Cell & Gene Therapies, 2019–2028 (US$ Million)

9.1.1.1.2          China: Biopharmaceuticals Market, by Application, 2019–2028 (US$ Million)

9.1.1.2          Japan: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.1          Japan: Biopharmaceuticals Market, by Product Type, 2019–2028 (US$ Million)

9.1.1.2.1.1        Japan: Biopharmaceuticals Market, by Recombinant Vaccines, 2019–2028 (US$ Million)

9.1.1.2.1.2        Japan: Biopharmaceuticals Market, by Conventional Vaccines, 2019–2028 (US$ Million)

9.1.1.2.1.3        Japan: Biopharmaceuticals Market, by Recombinant Growth Factors, 2019–2028 (US$ Million)

9.1.1.2.1.4        Japan: Biopharmaceuticals Market, by Purified Proteins, 2019–2028 (US$ Million)

9.1.1.2.1.5        Japan: Biopharmaceuticals Market, by Recombinant Proteins, 2019–2028 (US$ Million)

9.1.1.2.1.6        Japan: Biopharmaceuticals Market, by Recombinant Hormones, 2019–2028 (US$ Million)

9.1.1.2.1.7        Japan: Biopharmaceuticals Market, by Recombinant Enzymes, 2019–2028 (US$ Million)

9.1.1.2.1.8        Japan: Biopharmaceuticals Market, by Cell & Gene Therapies, 2019–2028 (US$ Million)

9.1.1.2.2          Japan: Biopharmaceuticals Market, by Application, 2019–2028 (US$ Million)

9.1.1.3          India: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.1          India: Biopharmaceuticals Market, by Product Type, 2019–2028 (US$ Million)

9.1.1.3.1.1        India: Biopharmaceuticals Market, by Recombinant Vaccines, 2019–2028 (US$ Million)

9.1.1.3.1.2        India: Biopharmaceuticals Market, by Conventional Vaccines, 2019–2028 (US$ Million)

9.1.1.3.1.3        India: Biopharmaceuticals Market, by Recombinant Growth Factors, 2019–2028 (US$ Million)

9.1.1.3.1.4        India: Biopharmaceuticals Market, by Purified Proteins, 2019–2028 (US$ Million)

9.1.1.3.1.5        India: Biopharmaceuticals Market, by Recombinant Proteins, 2019–2028 (US$ Million)

9.1.1.3.1.6        India: Biopharmaceuticals Market, by Recombinant Hormones, 2019–2028 (US$ Million)

9.1.1.3.1.7        India: Biopharmaceuticals Market, by Recombinant Enzymes, 2019–2028 (US$ Million)

9.1.1.3.1.8        India: Biopharmaceuticals Market, by Cell & Gene Therapies, 2019–2028 (US$ Million)

9.1.1.3.2          India: Biopharmaceuticals Market, by Application, 2019–2028 (US$ Million)

9.1.1.4          South Korea: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.1          South Korea: Biopharmaceuticals Market, by Product Type, 2019–2028 (US$ Million)

9.1.1.4.1.1        South Korea: Biopharmaceuticals Market, by Recombinant Vaccines, 2019–2028 (US$ Million)

9.1.1.4.1.2        South Korea: Biopharmaceuticals Market, by Conventional Vaccines, 2019–2028 (US$ Million)

9.1.1.4.1.3        South Korea: Biopharmaceuticals Market, by Recombinant Growth Factors, 2019–2028 (US$ Million)

9.1.1.4.1.4        South Korea: Biopharmaceuticals Market, by Purified Proteins, 2019–2028 (US$ Million)

9.1.1.4.1.5        South Korea: Biopharmaceuticals Market, by Recombinant Proteins, 2019–2028 (US$ Million)

9.1.1.4.1.6        South Korea: Biopharmaceuticals Market, by Recombinant Hormones, 2019–2028 (US$ Million)

9.1.1.4.1.7        South Korea: Biopharmaceuticals Market, by Recombinant Enzymes, 2019–2028 (US$ Million)

9.1.1.4.1.8        South Korea: Biopharmaceuticals Market, by Cell & Gene Therapies, 2019–2028 (US$ Million)

9.1.1.4.2          South Korea: Biopharmaceuticals Market, by Application, 2019–2028 (US$ Million)

9.1.1.5          Australia: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.5.1          Australia: Biopharmaceuticals Market, by Product Type, 2019–2028 (US$ Million)

9.1.1.5.1.1        Australia: Biopharmaceuticals Market, by Recombinant Vaccines, 2019–2028 (US$ Million)

9.1.1.5.1.2        Australia: Biopharmaceuticals Market, by Conventional Vaccines, 2019–2028 (US$ Million)

9.1.1.5.1.3        Australia: Biopharmaceuticals Market, by Recombinant Growth Factors, 2019–2028 (US$ Million)

9.1.1.5.1.4        Australia: Biopharmaceuticals Market, by Purified Proteins, 2019–2028 (US$ Million)

9.1.1.5.1.5        Australia: Biopharmaceuticals Market, by Recombinant Proteins, 2019–2028 (US$ Million)

9.1.1.5.1.6        Australia: Biopharmaceuticals Market, by Recombinant Hormones, 2019–2028 (US$ Million)

9.1.1.5.1.7        Australia: Biopharmaceuticals Market, by Recombinant Enzymes, 2019–2028 (US$ Million)

9.1.1.5.1.8        Australia: Biopharmaceuticals Market, by Cell & Gene Therapies, 2019–2028 (US$ Million)

9.1.1.5.2          Australia: Biopharmaceuticals Market, by Application, 2019–2028 (US$ Million)

9.1.1.6          Rest of Asia Pacific: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.6.1          Rest of Asia Pacific: Biopharmaceuticals Market, by Product Type, 2019–2028 (US$ Million)

9.1.1.6.1.1        Rest of Asia Pacific: Biopharmaceuticals Market, by Recombinant Vaccines, 2019–2028 (US$ Million)

9.1.1.6.1.2        Rest of Asia Pacific: Biopharmaceuticals Market, by Conventional Vaccines, 2019–2028 (US$ Million)

9.1.1.6.1.3        Rest of Asia Pacific: Biopharmaceuticals Market, by Recombinant Growth Factors, 2019–2028 (US$ Million)

9.1.1.6.1.4        Rest of Asia Pacific: Biopharmaceuticals Market, by Purified Proteins, 2019–2028 (US$ Million)

9.1.1.6.1.5        Rest of Asia Pacific: Biopharmaceuticals Market, by Recombinant Proteins, 2019–2028 (US$ Million)

9.1.1.6.1.6        Rest of Asia Pacific: Biopharmaceuticals Market, by Recombinant Hormones, 2019–2028 (US$ Million)

9.1.1.6.1.7        Rest of Asia Pacific: Biopharmaceuticals Market, by Recombinant Enzymes, 2019–2028 (US$ Million)

9.1.1.6.1.8        Rest of Asia Pacific: Biopharmaceuticals Market, by Cell & Gene Therapies, 2019–2028 (US$ Million)

9.1.1.6.2          Rest of Asia Pacific: Biopharmaceuticals Market, by Application, 2019–2028 (US$ Million)

10.        Asia Pacific Biopharmaceuticals Market – Industry Landscape

10.1      Overview

10.2      Organic Growth Strategies

10.2.1     Overview

10.3      Inorganic Growth Strategies

10.3.1     Overview

11.        Company Profiles

11.1      Amgen Inc

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      AbbVie Inc

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Eli Lilly and Co

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Bristol-Myers Squibb Co

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Johnson & Johnson

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      Boehringer Ingelheim International GmbH

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      Thermo Fisher Scientific Inc

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8      AGC Biologics AS

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Products and Services

11.8.4     Financial Overview

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9      Lonza Group AG

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Products and Services

11.9.4     Financial Overview

11.9.5     SWOT Analysis

11.9.6     Key Developments

11.10   WuXi Biologics Inc

11.10.1  Key Facts

11.10.2  Business Description

11.10.3  Products and Services

11.10.4  Financial Overview

11.10.5  SWOT Analysis

11.10.6  Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary of Terms

LIST OF TABLES

Table 1.             Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             China Biopharmaceuticals Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 3.             China Biopharmaceuticals Market, by Recombinant Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 4.             China Biopharmaceuticals Market, by Conventional Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 5.             China Biopharmaceuticals Market, by Recombinant Growth Factors – Revenue and Forecast to 2028 (US$ Million)

Table 6.             China Biopharmaceuticals Market, by Purified Proteins – Revenue and Forecast to 2028 (US$ Million)

Table 7.             China Biopharmaceuticals Market, by Recombinant Proteins – Revenue and Forecast to 2028 (US$ Million)

Table 8.             China Biopharmaceuticals Market, by Recombinant Hormones – Revenue and Forecast to 2028 (US$ Million)

Table 9.             China Biopharmaceuticals Market, by Recombinant Enzymes – Revenue and Forecast to 2028 (US$ Million)

Table 10.          China Biopharmaceuticals Market, by Cell & Gene Therapies – Revenue and Forecast to 2028 (US$ Million)

Table 11.          China Biopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Japan Biopharmaceuticals Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Japan Biopharmaceuticals Market, by Recombinant Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Japan Biopharmaceuticals Market, by Conventional Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Japan Biopharmaceuticals Market, by Recombinant Growth Factors – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Japan Biopharmaceuticals Market, by Purified Proteins – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Japan Biopharmaceuticals Market, by Recombinant Proteins – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Japan Biopharmaceuticals Market, by Recombinant Hormones – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Japan Biopharmaceuticals Market, by Recombinant Enzymes – Revenue and Forecast to 2028 (US$ Million)

Table 20.          Japan Biopharmaceuticals Market, by Cell & Gene Therapies – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Japan Biopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 22.          India Biopharmaceuticals Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 23.          India Biopharmaceuticals Market, by Recombinant Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 24.          India Biopharmaceuticals Market, by Conventional Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 25.          India Biopharmaceuticals Market, by Recombinant Growth Factors – Revenue and Forecast to 2028 (US$ Million)

Table 26.          India Biopharmaceuticals Market, by Purified Proteins – Revenue and Forecast to 2028 (US$ Million)

Table 27.          India Biopharmaceuticals Market, by Recombinant Proteins – Revenue and Forecast to 2028 (US$ Million)

Table 28.          India Biopharmaceuticals Market, by Recombinant Hormones – Revenue and Forecast to 2028 (US$ Million)

Table 29.          India Biopharmaceuticals Market, by Recombinant Enzymes – Revenue and Forecast to 2028 (US$ Million)

Table 30.          India Biopharmaceuticals Market, by Cell & Gene Therapies – Revenue and Forecast to 2028 (US$ Million)

Table 31.          India Biopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 32.          South Korea Biopharmaceuticals Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 33.          South Korea Biopharmaceuticals Market, by Recombinant Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 34.          South Korea Biopharmaceuticals Market, by Conventional Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 35.          South Korea Biopharmaceuticals Market, by Recombinant Growth Factors – Revenue and Forecast to 2028 (US$ Million)

Table 36.          South Korea Biopharmaceuticals Market, by Purified Proteins – Revenue and Forecast to 2028 (US$ Million)

Table 37.          South Korea Biopharmaceuticals Market, by Recombinant Proteins – Revenue and Forecast to 2028 (US$ Million)

Table 38.          South Korea Biopharmaceuticals Market, by Recombinant Hormones – Revenue and Forecast to 2028 (US$ Million)

Table 39.          South Korea Biopharmaceuticals Market, by Recombinant Enzymes – Revenue and Forecast to 2028 (US$ Million)

Table 40.          South Korea Biopharmaceuticals Market, by Cell & Gene Therapies – Revenue and Forecast to 2028 (US$ Million)

Table 41.          South Korea Biopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 42.          Australia Biopharmaceuticals Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 43.          Australia Biopharmaceuticals Market, by Recombinant Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 44.          Australia Biopharmaceuticals Market, by Conventional Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 45.          Australia Biopharmaceuticals Market, by Recombinant Growth Factors – Revenue and Forecast to 2028 (US$ Million)

Table 46.          Australia Biopharmaceuticals Market, by Purified Proteins – Revenue and Forecast to 2028 (US$ Million)

Table 47.          Australia Biopharmaceuticals Market, by Recombinant Proteins – Revenue and Forecast to 2028 (US$ Million)

Table 48.          Australia Biopharmaceuticals Market, by Recombinant Hormones – Revenue and Forecast to 2028 (US$ Million)

Table 49.          Australia Biopharmaceuticals Market, by Recombinant Enzymes – Revenue and Forecast to 2028 (US$ Million)

Table 50.          Australia Biopharmaceuticals Market, by Cell & Gene Therapies – Revenue and Forecast to 2028 (US$ Million)

Table 51.          Australia Biopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 52.          Rest of Asia Pacific Biopharmaceuticals Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 53.          Rest of Asia Pacific Biopharmaceuticals Market, by Recombinant Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 54.          Rest of Asia Pacific Biopharmaceuticals Market, by Conventional Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 55.          Rest of Asia Pacific Biopharmaceuticals Market, by Recombinant Growth Factors – Revenue and Forecast to 2028 (US$ Million)

Table 56.          Rest of Asia Pacific Biopharmaceuticals Market, by Purified Proteins – Revenue and Forecast to 2028 (US$ Million)

Table 57.          Rest of Asia Pacific Biopharmaceuticals Market, by Recombinant Proteins – Revenue and Forecast to 2028 (US$ Million)

Table 58.          Rest of Asia Pacific Biopharmaceuticals Market, by Recombinant Hormones – Revenue and Forecast to 2028 (US$ Million)

Table 59.          Rest of Asia Pacific Biopharmaceuticals Market, by Recombinant Enzymes – Revenue and Forecast to 2028 (US$ Million)

Table 60.          Rest of Asia Pacific Biopharmaceuticals Market, by Cell & Gene Therapies – Revenue and Forecast to 2028 (US$ Million)

Table 61.          Rest of Asia Pacific Biopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 62.          Recent Organic Growth Strategies in Biopharmaceuticals Market

Table 63.          Recent Inorganic Growth Strategies in the Asia Pacific biopharmaceuticals market

Table 64.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Asia Pacific Biopharmaceuticals Market Segmentation

Figure 2.           Asia Pacific Biopharmaceuticals Market, by Country

Figure 3.           Asia Pacific Biopharmaceuticals Market Overview

Figure 4.           Monoclonal Antibodies Segment Held Largest Share of Product Type Segment in Asia Pacific Biopharmaceuticals Market

Figure 5.           China Expected to Show Remarkable Growth During Forecast Period

Figure 6.           Asia Pacific: PEST Analysis

Figure 7.           Experts’ Opinion

Figure 8.           Asia Pacific Biopharmaceuticals Market: Impact Analysis of Drivers and Restraints

Figure 9.           Asia Pacific Biopharmaceuticals Market – Revenue Forecast and Analysis – 2020–2028

Figure 10.        Asia Pacific Biopharmaceuticals Market Revenue Share, by Product Type 2021 & 2028 (%)

Figure 11.        Monoclonal Antibodies: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Recombinant Vaccines: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Cancer Vaccine: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Malaria Vaccine: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Ebola Vaccine: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Hepatitis-B Vaccine: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Tetanus Vaccine: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Diphtheria Vaccine: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Cholera Vaccine: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Others: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Conventional Vaccines: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Polio Vaccine: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Pox Vaccine: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Other Conventional Vaccine: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Recombinant Growth Factors: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Erythropoietin: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Granulocyte Colony Stimulating Factor: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Purified Proteins: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Leukemia Inhibitory Factor (LIF): Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        P53 Protein: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        P38 Protein: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Other Purified Proteins: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Recombinant Proteins: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Serum Albumin: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Amyloid Protein: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        Defensin: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37.        Transferrin: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Recombinant Hormones: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39.        Recombinant Human Growth Hormones: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40.        Recombinant Insulin: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41.        Other Recombinant Hormones: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42.        Recombinant Enzymes: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43.        Enterokinase: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44.        Cyclase: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45.        Caspase: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46.        Cathepsin: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 47.        Cell and Gene Therapies: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 48.        Allogenic Products: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 49.        Autologous Products: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 50.        Acellular Products: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 51.        Cytokines/Interferon/Interleukins: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 52.        Others (mRNA Based Therapeutics, etc.): Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 53.        Asia Pacific Biopharmaceuticals Market, by Application 2021 & 2028 (%)

Figure 54.        Oncology: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 55.        Inflammatory and Infectious Diseases: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 56.        Autoimmune Disorders: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 57.        Metabolic Disorders: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 58.        Hormonal Disorders and Growth Failure: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 59.        Cardiovascular Diseases: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 60.        Neurological Diseases: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 61.        Other Therapeutic Applications: Asia Pacific Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 62.        Asia Pacific: Biopharmaceuticals Market, by Key Country – Revenue (2021) (US$ Million)

Figure 63.        China: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 64.        Japan: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 65.        India: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 66.        South Korea: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 67.        Australia: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 68.        Rest of Asia Pacific: Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)